IBRX
Immunitybio Inc
8.50$
+0.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +503.1% | -13.5% | -21.1% | -27.3% | -21.3% | +54.7% | +111.8% | -22.7% | +39.2% | -24.1% | +31.1% | |
| – | +401.1% | -31.1% | -35.4% | -33.0% | -37.2% | +100.4% | +199.3% | -58.0% | +109.2% | -37.2% | +70.6% | |
| – | +197.6% | -95.4% | +195.3% | -29.5% | -7.8% | +125.1% | +418.7% | -42.2% | +153.7% | -46.0% | -38.4% | |
| – | +397.8% | -32.4% | -35.6% | -42.1% | -30.3% | +86.0% | +230.1% | -66.2% | +148.6% | -43.8% | +62.1% | |
| – | +1,123.4% | +50.4% | -52.8% | +867.2% | -97.5% | +561.1% | -33.4% | +41.8% | +67.6% | -16.3% | +1,506.4% | |
| – | – | – | – | – | – | – | – | – | -100.0% | – | -89.0% | |
| – | – | – | +295.9% | -61.4% | -6.2% | +4.3% | +186.1% | +73.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | |
| – | +773.3% | -30.3% | -44.4% | +327.6% | -0.1% | -87.9% | -2.9% | +1,308.7% | -14.5% | -12.1% | -13.2% | |
| – | +351.3% | +121.8% | +31.2% | +13.8% | -37.6% | +1,414.3% | +109.7% | +13.9% | +34.3% | -20.1% | +15.0% | |
| – | +155.6% | +104.2% | +66.2% | +30.6% | -57.6% | +489.4% | +441.6% | +35.7% | -88.4% | -5.7% | +12.4% | |
| – | -14.0% | -18.0% | -11.2% | +481.3% | +310.7% | +26.5% | +5,926.9% | +43.8% | -98.8% | +42.4% | +24.4% | |
| – | +84.4% | +94.0% | +45.0% | -52.4% | -37.4% | +558.1% | -0.8% | +84.1% | -56.2% | -26.9% | +3.8% | |
| – | – | – | – | – | – | – | +20.4% | -21.2% | +182.5% | -32.2% | +3.3% | |
| – | +509.3% | -17.6% | -25.4% | -33.3% | -17.3% | -199.3% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -9.4% | +14.6% | -1.7% | +0.8% | +17.9% | +0.0% | +1.6% | +2.7% | +27.2% | +37.7% | +31.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.